Stockreport

Cabaletta Bio to Participate in the Jefferies Global Healthcare Conference

Cabaletta Bio, Inc.  (CABA) 
PDF PHILADELPHIA, May 29, 2024 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first [Read more]